X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cik cells (199) 199
index medicus (195) 195
immunotherapy (182) 182
humans (175) 175
oncology (127) 127
adoptive immunotherapy (115) 115
cancer (111) 111
cytokine-induced killer cells (111) 111
cytokines (100) 100
cytokine-induced killer cells - immunology (99) 99
chemotherapy (94) 94
t-cells (87) 87
immunology (85) 85
dendritic cells (84) 84
animals (81) 81
killer cells (78) 78
cytotoxicity (74) 74
female (73) 73
medicine, research & experimental (61) 61
male (60) 60
cell line, tumor (55) 55
cytokine-induced killer cells - transplantation (54) 54
induced killer-cells (54) 54
cik (53) 53
hematology (53) 53
mice (53) 53
antitumor-activity (52) 52
immunotherapy, adoptive - methods (49) 49
middle aged (49) 49
therapy (49) 49
cell biology (47) 47
tumors (47) 47
care and treatment (44) 44
lymphocytes (43) 43
adult (39) 39
aged (37) 37
expression (37) 37
t cells (35) 35
analysis (34) 34
solid tumors (34) 34
apoptosis (33) 33
cytotoxicity, immunologic (33) 33
biotechnology & applied microbiology (31) 31
cancer therapies (31) 31
dendritic cells - immunology (31) 31
dc-cik (30) 30
in-vitro (30) 30
neoplasms - therapy (30) 30
neoplasms - immunology (29) 29
treatment outcome (29) 29
pharmacology & pharmacy (28) 28
phase-i (28) 28
research (28) 28
clinical trials (27) 27
combined modality therapy (27) 27
health aspects (27) 27
killer cells, natural - immunology (27) 27
lung cancer (27) 27
medicine & public health (27) 27
leukemia (26) 26
lung-cancer (26) 26
lymphoma (26) 26
carcinoma (25) 25
hepatocellular-carcinoma (25) 25
biochemistry & molecular biology (24) 24
cells, cultured (24) 24
efficacy (24) 24
flow cytometry (24) 24
cancer research (23) 23
drug therapy (23) 23
immunotherapy, adoptive (23) 23
antigens (22) 22
cytokine-induced killer cell (21) 21
gastric-cancer (21) 21
prognosis (21) 21
transplantation (21) 21
acute myeloid-leukemia (20) 20
cik cell (20) 20
combination (20) 20
in-vivo (20) 20
internal medicine (20) 20
immunotherapy - methods (19) 19
original research (19) 19
activation (18) 18
coculture techniques (18) 18
cytokine-induced killer cells - cytology (18) 18
regulatory t-cells (18) 18
cd8 t-cells (17) 17
cell proliferation (17) 17
ciks (17) 17
cytokine-induced killer cells - metabolism (17) 17
hepatocellular carcinoma (17) 17
immune response (17) 17
severe combined immunodeficiency (17) 17
article (16) 16
cells (16) 16
immunity (16) 16
melanoma (16) 16
meta-analysis (16) 16
patients (16) 16
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (422) 422
Chinese (16) 16
German (2) 2
Polish (2) 2
Italian (1) 1
Korean (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2013, Volume 161, Issue 3, pp. 389 - 401
Journal Article
Journal of Immunotherapy, ISSN 1524-9557, 11/2013, Volume 36, Issue 9, pp. 462 - 467
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, p. e93591
Journal Article
International Journal of Cancer, ISSN 0020-7136, 10/2016, Volume 139, Issue 8, pp. 1799 - 1809
Journal Article
Cytotherapy, ISSN 1465-3249, 2012, Volume 14, Issue 1, pp. 91 - 103
Abstract Background aims Cytokine-induced killer (CIK) cells may serve as an alternative approach to adoptive donor lymphocyte infusions (DLI) for patients... 
Advanced Basic Science | Other | cytokine-induced killer cells | interleukin-15 | NKG2D | killer-cell immunoglobulin-like receptor–HLA mismatch | leukemia cells | killer-cell immunoglobulin-like receptor-HLA mismatch | MEDICINE, RESEARCH & EXPERIMENTAL | SEVERE COMBINED IMMUNODEFICIENCY | CORD BLOOD | CIK CELLS | ANTITUMOR-ACTIVITY | VERSUS-HOST-DISEASE | CELL & TISSUE ENGINEERING | CELL BIOLOGY | INTERFERON-GAMMA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | IN-VIVO | REGULATORY T-CELLS | HEMATOLOGY | EXPRESSION | ADOPTIVE IMMUNOTHERAPY | Recurrence | Adjuvants, Immunologic - pharmacology | Humans | NK Cell Lectin-Like Receptor Subfamily K - immunology | Killer Cells, Natural - pathology | Transplantation, Homologous | Contraindications | Feasibility Studies | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | NK Cell Lectin-Like Receptor Subfamily K - metabolism | Killer Cells, Natural - immunology | Lymphocytes, Tumor-Infiltrating - metabolism | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Immunotherapy, Adoptive | Antigens, Neoplasm - immunology | Leukocyte Transfusion | Hematopoietic Stem Cell Transplantation | Lymphocytes, Tumor-Infiltrating - drug effects | NK Cell Lectin-Like Receptor Subfamily K - genetics | Polymorphism, Genetic | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Interleukin-15 - pharmacology | Lymphocytes, Tumor-Infiltrating - pathology | Cell Line, Tumor | Killer Cells, Natural - metabolism | Immunity, Cellular | Cytotoxicity, Immunologic | Lymphocytes, Tumor-Infiltrating - immunology
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2017, Volume 23, Issue 9, pp. 2277 - 2288
Purpose: The MHC-unrestricted activity of cytokine-induced killer (CIK) cells against chemo-surviving melanoma cancer stem cells (mCSC) was explored, as CSCs... 
METASTATIC MELANOMA | ONCOLOGY | LENTIVIRUS VECTOR | IN-VIVO | THERAPY RESISTANCE | OPEN-LABEL | ACUTE MYELOID-LEUKEMIA | HLA BARRIERS | CIK CELLS | ANTITUMOR-ACTIVITY | CD8(+) T-CELLS | Nitrosourea Compounds - administration & dosage | Humans | Oximes - administration & dosage | Imidazoles - administration & dosage | Neoplastic Stem Cells - immunology | Lentivirus - genetics | Immunotherapy, Adoptive - methods | Carcinogenesis - immunology | Carcinogenesis - genetics | Neoplasm Recurrence, Local | Drug Resistance, Neoplasm - immunology | Melanoma - pathology | Neoplastic Stem Cells - transplantation | Cytokine-Induced Killer Cells - immunology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Melanoma - immunology | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Cytokine-Induced Killer Cells - transplantation | Cell Line, Tumor | Mice | Organophosphorus Compounds - administration & dosage | Melanoma - therapy | Cytotoxicity, Immunologic | Autografts | Animal models | Cytokines | Oct-4 protein | Immunodeficiency | Melanoma | Chemoresistance | Stem cell transplantation | Gene expression | Anticancer properties | Infusion | Design engineering | Killer cells | Chemotherapy | Dilution | Major histocompatibility complex | Allografts | Experimental design | Immunotherapy | Stem cells | Lysis | Xenografts | Antitumor activity | Cancer
Journal Article
Journal Article
Cancer Biotherapy and Radiopharmaceuticals, ISSN 1084-9785, 04/2012, Volume 27, Issue 3, pp. 21 - 220